Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00681486Phase 3Completed
Phase 3, randomised trial of human ghrelin in cancer cachexia (2 arms), sponsored by University of Gothenburg. Primary endpoint: Food intake. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00681486.